Catalyst Wire Dossier Catalyst Wire Dossier

Ramelteon Sublingual

ramelteon · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ramelteon Sublingual, covering 2016-05-16 to 2016-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder [Phase 3]

See pricing